MP Biomedicals LLC

Valley Center, CA, United States

MP Biomedicals LLC

Valley Center, CA, United States
SEARCH FILTERS
Time filter
Source Type

— Global Podophyllin Industry Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Companies profiled in this report are MP Biomedicals, Perrigo, Himpharm, Haoxiang, Haoxuan, Dajiang, Huahai, Huawei in terms of Basic Information, Manufacturing Base, Sales Area and Its Competitors, Sales, Revenue, Price and Gross Margin (2012-2017). Split by Product Types, with sales, revenue, price, market share of each type, can be divided into • 50% of Podophyllin Split by applications, this report focuses on sales, market share and growth rate of Podophyllin in each application, can be divided into • Podophyllotoxin Tincture • Podophyllotoxin Cream • Others Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/424320 Table of Content: 1 Podophyllin Market Overview 2 Global Podophyllin Sales, Revenue (Value) and Market Share by Manufacturers 3 Global Podophyllin Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 4 Global Podophyllin Manufacturers Profiles/Analysis 5 North America Podophyllin Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6 Latin America Podophyllin Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 7 Europe Podophyllin Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 8 Asia-Pacific Podophyllin Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 9 Middle East and Africa Podophyllin Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 10 Podophyllin Manufacturing Cost Analysis 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 13 Market Effect Factors Analysis 14 Global Podophyllin Market Forecast (2017-2022) 15 Research Findings and Conclusion 16 Appendix Inquire more for more details about this report at: https://www.themarketreports.com/report/ask-your-query/424320 For more information, please visit https://www.themarketreports.com/report/2017-2022-global-top-countries-podophyllin-market-report


Receive press releases from iHealthcareAnalyst, Inc.: By Email Hepatitis E Diagnostic Tests Market by Test Types, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021. Maryland Heights, MO, April 30, 2017 --( Browse Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/ The global hepatitis E diagnostic tests market segmentation is based on test type (ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, Others), end users (diagnostic laboratories, hospitals, point-of-care). The global hepatitis E diagnostic tests market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global hepatitis E diagnostic tests market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global hepatitis E diagnostic tests market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. Major players operating in the global hepatitis E diagnostic tests market and profiled in this report include Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC, and Primerdesign Ltd. 1. Test Type 1.1. ELISA HEV IgM Test Kits 1.2. ELISA HEV IgG Test Kits 1.3. RT-PCR Test Kits 1.4. Others 2. End Users 2.1. Diagnostic Laboratories 2.2. Hospitals 2.3. Point-of-Care 2.4. Research Centers 3. Geography (Region, Country) 3.1. North America (U.S., Canada) 3.2. Latin America (Brazil, Mexico, Rest of LA) 3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 3.4. Asia Pacific (Japan, China, India, Rest of APAC) 3.5. Rest of the World 4. Company Profiles 4.1. Altana Diagnostics GmbH 4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 4.3. Biokit S.A. 4.4. Dia.Pro - Diagnostic Bioprobes s.r.l 4.5. F. Hoffmann-La Roche Ltd. 4.6. Fast-track diagnostics Ltd. 4.7. Fortress Diagnostics Limited 4.8. Mikrogen GmBH 4.9. MP Biomedicals, LLC 4.10. Primerdesign Ltd. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, April 30, 2017 --( PR.com )-- Hepatitis E is a liver disease caused by the hepatitis E virus (HEV), and the infection is found worldwide but most common in developing countries with limited access to essential water, sanitation, hygiene and health services. The commonly used tests for HEV infection include detection of IgM and IgG anti-HEV antibodies and detection of HEV RNA. Diagnosis of hepatitis E infection is usually based on the detection of specific IgM antibodies (ELISA). Additional tests include reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis E virus RNA in blood and/or stool samples, carried out in specialized laboratory facilities. Recently, a test for viral antigen detection in serum has been developed. Although several diagnostic assays for anti-HEV antibodies are available, they have undergone fairly limited testing and often provide discordant results, particularly for IgG antibodies. Improved validation of existing anti-HEV antibody assays or development of new assays with superior performance characteristics is urgently needed.Browse Hepatitis E Diagnostic Tests Market by Test Type (ELISA HEV IgM Test Kits, ELISA HEV IgG Test Kits, RT-PCR Test Kits, Others), End Users (Diagnostic Laboratories, Hospitals, Point-of-Care) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/The global hepatitis E diagnostic tests market segmentation is based on test type (ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, Others), end users (diagnostic laboratories, hospitals, point-of-care).The global hepatitis E diagnostic tests market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global hepatitis E diagnostic tests market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global hepatitis E diagnostic tests market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.Major players operating in the global hepatitis E diagnostic tests market and profiled in this report include Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC, and Primerdesign Ltd.1. Test Type1.1. ELISA HEV IgM Test Kits1.2. ELISA HEV IgG Test Kits1.3. RT-PCR Test Kits1.4. Others2. End Users2.1. Diagnostic Laboratories2.2. Hospitals2.3. Point-of-Care2.4. Research Centers3. Geography (Region, Country)3.1. North America (U.S., Canada)3.2. Latin America (Brazil, Mexico, Rest of LA)3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)3.4. Asia Pacific (Japan, China, India, Rest of APAC)3.5. Rest of the World4. Company Profiles4.1. Altana Diagnostics GmbH4.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.4.3. Biokit S.A.4.4. Dia.Pro - Diagnostic Bioprobes s.r.l4.5. F. Hoffmann-La Roche Ltd.4.6. Fast-track diagnostics Ltd.4.7. Fortress Diagnostics Limited4.8. Mikrogen GmBH4.9. MP Biomedicals, LLC4.10. Primerdesign Ltd.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/hepatitis-e-diagnostics-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill DriveMaryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


Li S.,University of Miami | Micic M.,MP Biomedicals LLC | Micic M.,University of California at Irvine | Orbulescu J.,MP Biomedicals LLC | And 2 more authors.
Journal of the Royal Society Interface | Year: 2012

Human islet amyloid polypeptide (hIAPP) is the source of the major component of the amyloid deposits found in the islets of Langerhans of around 95 per cent type 2 diabetic patients. The formation of aggregates and mature fibrils is thought to be responsible for the dysfunction and death of the insulin-producing pancreatic β-cells. Investigation on the conformation, orientation and self-assembly of the hIAPP at time zero could be beneficial for our understanding of its stability and aggregation process. To obtain these insights, the hIAPP at time zero was studied at the air-aqueous interface using the Langmuir monolayer technique. The properties of the hIAPP Langmuir monolayer at the air-aqueous interface on a NaCl subphase with pH 2.0, 5.6 and 9.0 were examined by surface pressure- and potential-area isotherms, UV-Vis absorption, fluorescence spectroscopy and Brewster angle microscopy. The conformational and orientational changes of the hIAPP Langmuir monolayer under different surface pressures were characterized by p-polarized infrared-reflection absorption spectroscopy, and the results did not show any prominent changes of conformation or orientation. The predominant secondary structure of the hIAPP at the air-aqueous interface was α-helix conformation, with a parallel orientation to the interface during compression. These results showed that the hIAPP Langmuir monolayer at the air-aqueous interface was stable, and no aggregate or domain of the hIAPP at the air-aqueous interface was observed during the time of experiments. © 2012 The Royal Society.


Liu W.,University of Miami | Johnson S.,University of Miami | Micic M.,MP Biomedicals LLC | Micic M.,University of California at Irvine | And 4 more authors.
Langmuir | Year: 2012

The human insulin (HI) Langmuir monolayer at the air-water interface was systematically investigated in the presence and absence of Zn(II) ions in the subphase. HI samples were dissolved in acidic (pH 2) and basic (pH 9) aqueous solutions and then spread at the air-water interface. Spectroscopic data of aqueous solutions of HI show a difference in HI conformation at different pH values. Moreover, the dynamics of the insulin protein showed a dependence on the concentration of Zn(II) ions. In the absence of Zn(II) ions in the subphase, the acidic and basic solutions showed similar behavior at the air-water interface. In the presence of Zn(II) ions in the subphase, the surface pressure-area and surface potential-area isotherms suggest that HI may aggregate at the air-water interface. It was observed that increasing the concentration of Zn(II) ions in the acidic (pH 2) aqueous solution of HI led to an increase of the area at a specific surface pressure. It was also seen that the conformation of HI in the basic (pH 9) medium had a reverse effect (decrease in the surface area) with the increase of the concentration of Zn(II) ions in solution. From the compression-decompression cycles we can conclude that the aggregated HI film at air-water interface is not stable and tends to restore a monolayer of monomers. These results were confirmed from UV-vis and fluorescence spectroscopy analysis. Infrared reflection-absorption and circular dichroism spectroscopy techniques were used to determine the secondary structure and orientation changes of HI by zinc ions. Generally, the aggregation process leads to a conformation change from ?-helix to β-strand and β-turn, and at the air-water interface, the aggregation process was likewise seen to induce specific orientations for HI in the acidic and basic media. A proposed surface orientation model is presented here as an explanation to the experimental data, shedding light for further research on the behavior of insulin as a Langmuir monolayer. © 2012 American Chemical Society.


Li S.,University of Miami | Mulloor J.J.,University of Miami | Wang L.,University of Miami | Ji Y.,University of Miami | And 5 more authors.
ACS Applied Materials and Interfaces | Year: 2014

Biosensing methods and devices using graphene oxide (GO) have recently been explored for detection and quantification of specific biomolecules from body fluid samples, such as saliva, milk, urine, and serum. For a practical diagnostics application, any sensing system must show an absence of nonselective detection of abundant proteins in the fluid matrix. Because lysozyme is an abundant protein in these body fluids (e.g., around 21.4 and 7 μg/mL of lysozyme is found in human milk and saliva from healthy individuals, and more than 15 or even 100 μg/mL in patients suffering from leukemia, renal disease, and sarcoidosis), it may interfere with detections and quantification if it has strong interaction with GO. Therefore, one fundamental question that needs to be addressed before any development of GO based diagnostics method is how GO interacts with lysozyme. In this study, GO has demonstrated a strong interaction with lysozyme. This interaction is so strong that we are able to subsequently eliminate and separate lysozyme from aqueous solution onto the surface of GO. Furthermore, the strong electrostatic interaction also renders the selective adsorption of lysozyme on GO from a mixture of binary and ternary proteins. This selectivity is confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), fluorescence spectroscopy, and UV-vis absorption spectroscopy. © 2014 American Chemical Society.


Thakur G.,University of Miami | Pao C.,University of Miami | Micic M.,MP Biomedicals LLC | Micic M.,University of California at Irvine | And 2 more authors.
Colloids and Surfaces B: Biointerfaces | Year: 2011

Lipid rafts being rich in cholesterol and sphingolipids are considered to provide ordered lipid environment in the neuronal membranes, where it is hypothesized that the cleavage of amyloid precursor protein (APP) to Aβ (1-40) and Aβ (1-42) takes place. It is highly likely that the interaction of lipid raft components like cholesterol, sphingomylein or GM1 leads to nucleation of Aβ and results in aggregation or accumulation of amyloid plaques. One has investigated surface pressure-area isotherms of the lipid raft and Aβ (1-40) Langmuir monolayer. The compression-decompression cycles and the stability of the lipid raft Langmuir monolayer are crucial parameters for the investigation of interaction of Aβ (1-40) with the lipid raft Langmuir monolayer. It was revealed that GM1 provides instability to the lipid raft Langmuir monolayer. Adsorption of Aβ (1-40) onto the lipid raft Langmuir monolayer containing neutral (POPC) or negatively charged phospholipid (DPPG) was examined. The adsorption isotherms revealed that the concentration of cholesterol was important for adsorption of Aβ (1-40) onto the lipid raft Langmuir monolayer containing POPC whereas for the lipid raft Langmuir monolayer containing DPPG:cholesterol or GM1 did not play any role. In situ UV-vis absorption spectroscopy supported the interpretation of results for the adsorption isotherms. © 2011 Elsevier B.V.


Trademark
Mp Biomedicals Llc | Date: 2010-07-20

Process kit used in scientific research laboratories to purify nucleic acids, the kit consisting primarily of a solution of sodium iodide, sodium chloride, and a suspension of silica in water; process kit used in medical laboratories to purify nucleic acids, the kit consisting primarily of a solution of sodium iodide, sodium chloride, and a suspension of silica in water.


Trademark
Mp Biomedicals Llc | Date: 2011-02-08

Scientific and laboratory apparatus for use in shaking vessels with a reciprocating motion.


Trademark
Mp Biomedicals Llc | Date: 2010-06-22

Scientific and laboratory apparatus for use in shaking vessels with a reciprocating motion.


News Article | November 23, 2016
Site: www.newsmaker.com.au

Industry from many centuries has utilized natural resources in the manufacturing of products that we use in our Daily lives. As the industry has expanded and brought in technological innovations, so have the different types of natural resources evolved in the process of manufacturing. Molecules derived from natural sources have become an important part of manufacturing process all over the globe. One of those widely used molecules are enzymes. From wine making to detergent manufacturing, enzymes have been used in myriad applications. One of the most widely used enzymes all over the globe is Cellulase. Cellulase is a group of enzymes that helps in the breakdown of the cellulose into smaller carbohydrates. The term Cellulase is also used to describe a mixture of enzymes working together to break down cellulose. Cellulase applications are not just limited to the healthcare and food and beverage industry. Industrial sector has widely adopted cellulase due to its catalyzing effect in cellulolysis Based on the Source, the Cellulasemarket is segmented into: Based on end use, the Cellulasemarket is segmented into: Cellulase is widely used in the processing of coffee, especially during the process of drying. Cellulase is also utilized in wine making due to its cellulolytic properties. Cellulase breaks down the skin of the grape and along with it removes tannins and the unpleasant aroma. Cellulase synergistically with other enzymes are also used to make fruit juices. With the exponential growth in the food and beverage industry, we can expect the cellulase market to grow at a healthy CAGR throughout our forecasted period of 2016-2026. Cellulase is also used in industrial applications to produce laundry detergents, cleaning and washing agents. With the burgeoning rise in the industrial sector, cellulase market is bound to witness an exponential growth throughut our forecasted period of 2016-2026. Cellulase is being recognized as an alternative to anti-biotic in the treatment of biofilms produced by Pseudomonas. With the double digit growth in the global healthcare industry and the struggle against anti-biotic resistant bacteria, we can expect the cellulase market to witness a healthy CAGR throughout our forecast period. Cellulase is also used in the burgeoning paper and pulp industry. The restraints for the cellulase market are that its production is quite costly. In terms of geography, the cellulase market has been divided in to five key regions; North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. The cellulase market is expected to exhibit an above average CAGR during the forecast period. Asia Pacific region is expected to witness a high demand for cellulase over the forecasted period. Highest growth is expected to be seen specifically from India and China. Significant growth will also be witness in Middle East and Africa, Eastern Europe and Latin America. Some of the key players in the cellulase market are Worthington Biochemical Corporation, MP Biomedicals LLC, Sigma-Aldrich Co. LLC, Prozmix LLC, Creative Enzymes, bioWORLD, Amano enzyme U.S.A., Amano Enzyme Inc., Zhongbei Bio-Chem Industry Co., Ltd., Hunan Hong Ying Biotech Co., Ltd.

Loading MP Biomedicals LLC collaborators
Loading MP Biomedicals LLC collaborators